Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-10

Clinical Trial Update: Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a Phase II/III trial evaluating recombinant human serum albumin in patients with cirrhosis and ascites, noting that the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recombinant Human Serum Albumin (recombinant human serum albumin)

Snippet

Sponsor: Protgen Ltd | Conditions: Cirrhotic Ascites | Phase 2, Phase 3 | Status: COMPLETED